Tenet Healthcare Corporation (NYSE:THC) went up by 8.07% from its latest closing price when compared to the 1-year high value of $39.37 and move down -38.63%, while THC stocks collected -13.12% of loss with the last five trading sessions. Press Release reported on 02/27/20 that Tenet to Participate in the Raymond James 41(st) Annual Institutional Investors Conference
Tenet Healthcare Corporation (NYSE:THC) Worth an Investment?
Tenet Healthcare Corporation (NYSE: THC) The 36 Months beta value for THC stocks is at 1.81, while of the analysts out of 0 who provided ratings for Tenet Healthcare Corporation stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $40.00 which is $10.84 above current price. THC currently has a short float of 7.93% and public float of 102.77 M with average trading volume of 1.06M shares.
THC Market Performance
THC stocks went down by -13.12% for the week, with the monthly drop of -13.18% and a quarterly performance of -14.12%, while its annual performance rate touched -3.37%. The simple moving average for the period of the last 20 days is -11.59% for THC stocks with the simple moving average of 6.83% for the last 200 days.
Analysts’ Opinion on Tenet Healthcare Corporation (NYSE:THC)
Many brokerage firms have already submitted their reports for THC stocks, with JP Morgan repeating the rating for THC shares by setting it to “Neutral”. The predicted price for THC socks in the upcoming period according to JP Morgan is $34 based on the research report published on February 26, 2020.
UBS, on the other hand, stated in their research note that they expect to see THC stock at the price of $34. The rating they have provided for THC stocks is “Buy” according to the report published on December 9, 2019.
Credit Suisse gave “ Outperform” rating to THC stocks, setting the target price at $36 in the report published on November 6, 2019.
THC Stocks -18.73% Far from 50 Day Moving Average
After a stumble in the market that brought THC to its low price for the period of the last 52 weeks, Tenet Healthcare Corporation was unable to take a rebound, for now settling with -27.86% of loss for the given period.
The stock volatility was left at 5.24%, however, within the period of a single month, the volatility rate increased by 11.22%, while the shares sank at the distance of -10.24% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -24.45% lower at the present time.
In the course of the last 5 trading sessions, THC went down by -13.12%, which changed the moving average for the period of 200 days to the total of +35.95% of gains for the stock in comparison to the 20-day moving average settled at $31.96. In addition, Tenet Healthcare Corporation saw -25.32% in overturn over the period of a single year with a tendency to cut further losses.
THC Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Tenet Healthcare Corporation (THC), starting from Andrews Audrey T., who sold 65,360 shares at the price of $30.59 back on Nov 18. After this action, Rushing now owns 56,602 shares of Tenet Healthcare Corporation, valued at $1,999,362 with the latest closing price.
GLENVIEW CAPITAL MANAGEMENT, L, the 10% Owner of Tenet Healthcare Corporation, bought 39,665 shares at the value of $20.50 during a trade that took place back on Oct 03, which means that GLENVIEW CAPITAL MANAGEMENT, L is holding 19,708,959 shares at the value of $813,093 based on the most recent closing price.
THC Stock Fundamentals
The current profitability levels are settled at +9.09 for the present operating margin and +9.09 for gross margin. The net margin for Tenet Healthcare Corporation stands at -1.32. Equity return holds the value 97.30%, with -1.00% for asset returns.